• Every dose printed on the panel
  • No proprietary blends
  • Studies linked by PubMed ID
  • Single-active formulas
  • 30-day money-back guarantee

Berberine HCl

Also called Berberine hydrochloride, Berberine HCL

A yellow alkaloid found in the bark and roots of plants such as Berberis. Most research used berberine HCl at 900–1,500 mg a day in divided doses. Our Berberine gives about 73 mg of actual berberine per serving, from an 8% extract plus a small amount of 97% berberine HCl.

Dose used in research 900-1,500 mg per day, in divided doses

Berberine is one of the few supplement ingredients with a genuinely large randomised literature behind it. Four independent meta-analyses agree on the direction of the lipid effect, and the pooled trials run to several thousand participants.

Two caveats decide how we talk about it. First, nearly every trial enrolled people with dyslipidaemia, metabolic syndrome or type 2 diabetes, and the effect scales with how elevated the baseline was. Second, every endpoint is a biomarker: there is no trial data on clinical events, and nothing beyond roughly six months.

The dose matters more than the form. Trials used plain berberine HCl in divided doses, which is what we sell. Effect sizes from berberine phytosome or dihydroberberine trials are not transferable, because those forms change absorption substantially.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

The research

Human studies on this ingredient, with the design, sample size and dose each one used. Research on an ingredient is not a claim about any finished product.

  1. meta-analysisn = 21472018

    Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials

    Meta-analysis of 16 randomised trials. Pooled reductions in total cholesterol (-0.47 mmol/L), LDL (-0.38) and triglycerides (-0.28) in adults with dyslipidaemia. Dose used: 0.6-1.5 g/day.

  2. meta-analysisn = 17882023

    Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

    Meta-analysis of 18 placebo-controlled trials. LDL -0.46 and total cholesterol -0.48 mmol/L. HDL response differed by sex: higher in women, slightly lower in men. Dose used: 0.6-1.5 g/day.

  3. meta-analysisn = 17612023

    Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Meta-analysis of 20 randomised trials. Fasting glucose -0.52 mmol/L and HOMA-IR -0.85. Most participants had impaired glucose metabolism at baseline. Dose used: 0.6-1.5 g/day.

  4. meta-analysisn = 30482022

    Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis

    Meta-analysis of 37 randomised trials. Fasting glucose -0.82 mmol/L and HbA1c -0.63% in type 2 diabetes, with no excess adverse events. Effect scaled with baseline level. Dose used: 0.6-1.5 g/day.

  5. meta-analysisn = 41502024

    Effects of administering berberine alone or in combination on type 2 diabetes mellitus: a systematic review and meta-analysis

    Meta-analysis of 50 studies. The dose-bracketing reference for this ingredient: most trials clustered between 0.9 and 1.5 g per day over one to three months. Dose used: 0.9-1.5 g/day.

  6. meta-analysisn = 8892025

    Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials

    Meta-analysis of 12 placebo-controlled trials. Triglycerides -0.367 mmol/L and waist circumference -3.27 cm in metabolic syndrome. No effect on HDL or on blood pressure. Dose used: 300-1,500 mg/day.

  7. RCTn = 1162008

    Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine

    Randomised placebo-controlled trial over 3 months. Triglycerides fell 2.51 to 1.61 mmol/L and LDL 3.23 to 2.55 in adults with type 2 diabetes and dyslipidaemia. Dose used: 1.0 g/day.

  8. RCTn = 362008

    Efficacy of berberine in patients with type 2 diabetes mellitus

    Randomised trial against metformin over 3 months. Comparable glycaemic effect to metformin in newly diagnosed type 2 diabetes. 34.5% had transient gastrointestinal side effects. Dose used: 1.5 g/day (0.5 g three times daily).

Your cart (0)

Your cart is empty.

Shop the lineup